INTRODUCTION
Contact between phagocytic cells and opsonized bacteria or immune complexes, leads to a 'respiratory burst' in which dioxygen is consumed and intermediate reduced forms of dioxygen are released (Babior, 1978a,b) . The reduced oxygen products, superoxide (O2v-) and H202, are not particularly reactive unless a suitable transition-metal catalyst is available to facilitate a further reductive step to form the aggressive hydroxyl radical (OH'). These 'active oxygen' species facilitate microbial killing by phagocytic cells.
In rheumatoid arthritis it has been suggested that an aggressive oxidant such as the OH radical may be responsible for membrane damage, hyaluronic acid degradation, inactivation of proteinase inhibitors and destruction of several antioxidants within the synovial membrane (McCord, 1974; Greenwald & Moy, 1980; Blake et al., 1981; Gutteridge et al., 1984a) .
As mentioned above, the formation of a reactive species such as OH from°2 -and H202 requires a catalytic transition metal, and one of the most likely is iron. Iron, in a form able to catalyse OH' formation in the above reactions, can be released from ferritin by ascorbate (Gutteridge et al., 1983) or by O2' (Biemond et al., 1984; Thomas et al., 1985) , from transferrin at low pH values found in the microenvironment beneath adherent macrophages (Halliwell et al., 1985) , and from haem proteins by peroxides (Gutteridge, 1986a ). An assay in vitro has been developed to detect iron complexable to the drug bleomycin. The principles of this technique are summarized in Fig. 1 . When bound to bleomycin, iron in the presence of oxygen and ascorbate can degrade DNA, with the release of thiobarbituric acid-reactive products, which can be quantified and related to the amount of iron present . When this assay is applied to synovial fluids from arthritic patients, 'mal-placed' iron appears to be present in some of the fluids obtained from patients with both osteoarthritis and rheumatoid arthritis, Rowley et al., 1984) . However, more recent studies have shown that this iron is present, although transferrin is not 100% saturated, demonstrated by calculation and by direct measurement ofiron-binding capacity . The following studies were undertaken to understand the origin of the iron in synovial-fluid samples that is available to bleomycin under the assay conditions used.
MATERIALS AND METHODS Materials
Caeruloplasmin (human), DNA (calf thymus), yglobulins (rabbit), apotransferrin (human), albumin (human, fatty acid-free), diethyldithiocarbamate, bipyridyl and o-phenanthroline were from Sigma Chemical Co., Poole, Dorset, U.K. Immunodiffusion plates for albumin, transferrin, caeruloplasmin and lactoferrin were obtained from Behring Hoechst (Hounslow, Middx., U.K.). All other chemicals were of the highest purity available from BDH, Poole, Dorset, U.K.
Synovial-fluid samples were taken for authentic medical purposes into clear sterile plastic tubes and centrifuged (2000 g) (1981) and subsequently modified for greater precision and versatility (Gutteridge & Hou, 1986) was used in these studies. Briefly, 0.5 ml of DNA (1 mg/ml), 0.1 ml of bleomycin (0.1 unit/ml, or as shown in Figures and Tables), 0.1 ml of MgCl2 (50 mM), 0.1 ml of sample, 0.1 ml of buffer (1 M, as appropriate to the assay system) and 0.1 ml of ascorbic acid (7.5 mM) were added in the order stated to new clean plastic tubes and incubated at 37°C for 1 h in a shaking water bath. After incubation, 0.1 ml of EDTA (1 M) was added, followed by 0.5 ml of thiobarbituric acid (1%, w/v, in 50 mM-NaOH) and 0.5 ml of HCI (25%, v/v). The tube heated contents were transferred to glass tubes and heated for 10 min at 100°C, then cooled, and the resulting chromogen was extracted into 1.5 ml of butan-l-ol and the A532 was read. Appropriate blanks were prepared and subtracted from the A532 values.
Reagent concentrations shown are those added to the reaction mixture, and iron values are those present in the standard or sample.
(b) The bipyridyl reaction. Bipyridyl (0.1 mM) was dissolved in I ml of ethanol and made to 10 ml with metal-ion-free water (Chelex-resin-treated); 0.5 ml of transferrin (40% iron-loaded), 0.4 ml of buffer, 0.1 ml of ascorbic acid (7.5 mM) and 0.1 ml of bipyridyl (0.1 mM) were incubated at 37°C for 1 h and the increase in A530 was measured.
When iron release from synovial fluids was measured in the above bipyridyl reaction, 0.5 ml of synovial fluid was substituted for transferrin and the solution was ultrafiltered after incubation to allow accurate spectrophotometric measurement.
(c) Change in the absorbance of the transferrin-Fe3+ complex. When Fe3+ ions are complexed to transferrin, they produce a pink-coloured complex absorbing at 460 nm. Changes in A460 can be used to monitor changes in iron binding. The same reaction as described above for bipyridyl was used, but with the omission of bipyridyl, and with measurement of A460 changes.
Copper release from synovial fluids The phenanthroline assay for loosely bound copper (Gutteridge, 1984) was performed at pH 5.3 in the presence of ascorbate (0.75 mm final concn.), which replaced mercaptoethanol. Synovial-fluid antioxidant activities It has previously been shown that the antioxidant activities of fluids dependent on (i) iron-binding capacity and (ii) ferroxidase activity can be separated by careful control of the reaction conditions (Gutteridge, 1986b) . The mixture for reaction (i), measuring the iron-binding activity, contained 0.2 ml of phospholipid (bovine brain, 5 mg/ml), 0.2 ml of phosphate buffer (0.1 M; pH 7.4), 10 l1 of fluid and 0.02 ml of ascorbic acid (6 mM). The mixture for reaction (ii), measuring ferroxidase activity, contained 0.2 ml of phospholipid (5 mg/ml), 0.2 ml of phosphate buffer (0.1 M; pH 6.5), 20 /tl of fluid, 50 1ul of FeCl3 (0.5 mM) and 30 u1l of ascorbic acid (0.1 mM). Reaction mixtures were incubated at 37°C for 1 h. Thiobarbituric acid reactivity was developed in reactions (i) and (ii) by adding 0.5 ml of thiobarbituric acid (1 % in 50 mM-NaOH) and 0.5 ml of 25% HCI, then heating for 15 min at 100 'C. The chromogen was extracted into 1. 
RESULTS
Examination of knee-joint synovial fluids from patients with osteo-arthritis and rheumatoid arthritis shows that about 4000 of the fluids exhibit bleomycindetectable iron (BLM-iron) when the assay is carried out at an acid pH value. This must mean that (i) iron is present in the fluiid or (ii) iron is released from something under the assay conditions and nothing stops such iron from binding to bleomycin.
In the original studies Rowley et al., 1984) , the pH of the reaction undergoing incubation was not established. It is here shown to depend on a critical pH value of 5.3 (Fig. 2) , at which some fluids are positive and some negative to the appearance of iron in the bleomycin assay.
Determination of protein values for caeruloplasmin, transferrin, lactoferrin and albumin in the synovial fluids revealed wide variation. When these values were grouped under those patients showing the presence of BLM-iron (bleomycin-positive samples) and those not showing iron (bleomycin-negative samples), it can be seen that two distinct protein profiles arise, with the BLM-iron-positive patients having substantially lower caeruloplasmin and decreased transferrin values (Fig. 3) . Assuming measurements in each 'group' to be normally or log-normally distributed with equal variances, the probability that these groups have the same mean is shown in the legends to Figs. 3 and 4. In addition, lactoferrin could not be detected in the synovial fluids of this group (results not shown). This association is further supported by the finding that the ability of the fluids to inhibit peroxidizing lipids, dependent on iron-binding or ferroxidase activity, closely parallels the protein changes, showing substantial differences between the two groups (Fig. 4) . Preliminary studies have shown that synovial-fluid transferrin is not 100% (Fig. 2) . bleomycin assay, but substantially diminishes the However, the release of iron in the presence of inhibitory effect of copper ions on the detection of iron. 0.75 mM-ascorbate was restricted to a pH range of 5.5-6.0
Caeruloplasmin was also found to have an inhibitory when 40% -iron-loaded transferrin was treated in the effect on the bleomycin reaction, which could not be bipyridyl reaction (Fig. 5) or changes in absorbance of related to release of copper ions from the protein, in view transferrin were measured at 460 nm (Fig. 5) . A similar ofthe small effect ofdiethyldithiocarbamate in decreasing pattern of iron release was seen in the bleomycin assay this inhibition (Table 1) . Re-assay of BLM-ion-positive when H202 was substituted for ascorbate (Fig. 2) non-caeruloplasmin phenanthroline-detectable copper does not act in the same way as a simple copper salt in inhibiting the bleomycin reaction. Caeruloplasmin has both a ferroxidase activity and a weak ascorbate oxidase activity, and either or both of these could account for its inhibitory effect on the bleomycin assay (Table 1) . A bleomycin-Fe3+ complex will also degrade DNA in the presence of H202, so by substituting H202 for ascorbate the ascorbate oxidase activity of caeruloplasmin can be eliminated. Further, since Fe2+ ions are not involved in the degradation of DNA after addition of H202 (Fig. 1) , the ferroxidase activity of caeruloplasmin is also eliminated as an inhibitory mechanism, as well as the promoting effect of ascorbate on iron release from transferrin. The pHdependent release of iron from pure transferrin (40% -iron-loaded) to bleomycin in the presence of H202 is shown in Fig. 2 . Re-assays, in the presence of H202, of synovial fluids known to be either positive or negative for iron detection under the standard assay conditions are shown in Table 2 . A similar pattern of iron release is seen with H202, although the iron concentrations are lower.
Pressure filtration of synovial fluids through a 10000-Mr exclusion membrane suggested that the inhibitor(s) ofiron release in BLM-iron-negative synovial fluids at pH 5.3 is a high-Mr component (Table 3) .
Additions of apotransferrin, transferrin (40% -ironloaded), albumin and caeruloplasmin to a BLM-ironpositive synovial fluid are shown in Table 4 . Apotransferrin inhibits the detection of iron, whereas 40% -iron-loaded transferrin releases iron at pH 5.3 (Table 4) . Partly iron-loaded lactoferrin (human milk) also decreased BLM-iron when added at a concentration of 0.3 g/l to a BLM-positive fluid (results not shown). This concentration of lactoferrin is some 10 times greater than normal values found in synovial fluid (Bennett et al., 1973) . When iron-loaded transferrin was added to a BLM-iron-negative synovial fluid (Table 4) , there was a greater inhibitory effect on the release of iron from transferrin to bleomycin (Table 4) . A feature of the BLM-iron-positive fluids is their lowered contents of transferrin (Fig. 2) and lactoferrin, which could not be detected on radial immunodiffusion plates. Lactoferrin could, however, be detected in all the BLM-iron-negative fluids (results not shown).
DISCUSSION
Previous studies (Gutteridge et al., , 1984b , one in detail (Rowley et al., 1984) , have shown that some synovial fluids from patients with either osteo-arthritis or rheumatoid arthritis show the presence of BLM-iron at micromolar concentrations. The concentration of this iron correlates with disease severity, lipid peroxide and C-reactive-protein content of synovial fluids (Rowley et al., 1984) . The pH value of the unbuffered reaction mixture used by Rowley et al. (1984) was not stated, but it may well have been acidic, since discrimination of synovial fluids into BLM-iron-positive or -negative values is here shown to be critically dependent on a pH value of 5.3. Table 3 . Pressure filtration of synovial fluid through a 10000-
M,exclusion membrane
In reaction (3) equal volumes of fluids 'A' and 'B' were pre-mixed, and a volume of 0.1 ml was sampled. In reactions (4) and (5) 0.1 ml of sample 'B' was included in the reaction together with 0.1 ml of ultrafiltrate or protein concentrate.
Iron (aM) (Gutteridge, 1986b) , and a significant difference was seen in the antioxidant activities of the BLM-iron-positive and -negative groups.
When rheumatoid-arthritis sera or synovial fluids, not grouped according to the appearance of BLM-iron, are compared with fluids from either normal healthy controls or patients with osteoarthritis, the rheumatoid patients show a wide scatter of values but generally higher degrees of antioxidant protection against ironstimulated oxygen-radical damage, a feature ascribed to the higher contents of caeruloplasmin (Scudder et al., 1978; Cranfield et al., 1979; Gutteridge & Stocks, 1981) or the lower percentage iron saturation of the transferrin (Gutteridge, 1986b ). Here we show that both the rheumatoid-arthritis and osteoarthritis patients can be sub-divided to give a group who show low degrees of synovial-fluid antioxidant protection against iron-stimulated radical damage. These patients are those who show the presence of BLM-iron, a finding which might explain the previous correlations of BLM-iron with increased amounts of lipid peroxide (Rowley et al., 1984) .
Previous studies have shown that copper ions inhibit the detection of iron in the bleomycin reaction when not all the metal-binding sites of bleomycin are occupied (Gutteridge & Fu, 1981) and that caeruloplasmin does not inhibit when the bleomycin reaction is initiated by the addition of a ferrous salt (Gutteridge & Shute, 1981) . Here, using a bleomycin reaction dependent on the reduction of a ferric salt by ascorbate, I show that both copper ions and caeruloplasmin can influence the detection of iron. Caeruloplasmin has a ferroxidase (Osaki et al., 1966) and a weak ascorbate oxidase activity (Osaki et al., 1964) , and both activities appear to decrease the sensitivity of detection of a simple iron salt in the bleomycin reaction, although this is less marked when iron is measured in synovial fluid. If H202 is used as an 'oxygen activator' in place of ascorbate for the bleomycin reaction, then caeruloplasmin cannot influence iron detection by enzymic activities, since there is no ascorbate present, and no reduction of iron(III) to iron(II) has been observed in the presence of H202 (Melnyk et al., 1981) . Ascorbate also influences the pH at which iron is released from pure iron-loaded transferrin, and its replacement by H202 probably accounts for the lower iron values found in synovial fluids as well as the different pH-dependent pattern of iron release from pure iron-loaded transferrin. Lower iron values with H202 may also be ascribed to the non-redox cycling of bleomycin-bound iron in the presence of H202.
The addition of diethyldithiocarbamate to the bleomycin reaction prevented simple copper ions from inhibiting the detection of iron, and confirmed that a complexable form of copper was not inhibiting the detection of iron in synovial fluids, although some form of non-caeuloplasmin copper was available to phenanthroline.
Pure iron-loaded (40%) transferrin in the presence of ascorbate released iron to bleomycin over the entire acid pH range, whereas BLM-iron-positive fluids released iron only at a pH value of 5.3 or less. By using two different assay systems, the pH-dependent iron release from pure iron-loaded transferrin was studied by measuring the formation of a Fe2+-bipyridyl complex and the change in A460 as iron is released from transferrin. These two systems were little affected by addition ofcaeruloplasmin, in contrast with the bleomycin reaction, with ascorbate. The reason for this anomaly in the bleomycin-ascorbate reaction is probably related to the kinetics of iron redox cycling and the amount of reducing equivalents present in the final reaction mixture. In the bleomycin reaction the iron-bleomycin complex is acting catalytically, whereas in the bipyridyl reaction any Fe2+ ions formed are complexed in a fixed valence state to the bipyridyl molecule, where they are unavailable to transferrin. During the redox cycling of iron in the bleomycin reaction, superoxide radicals, H202 and organic peroxides are produced (Gutteridge & Hou, 1986 ), all of which may increase the pH-dependent release or iron from transferrin. Caeruloplasmin inhibited the release or iron above a pH value of 6.0, possibly by its ascorbate oxidase activity lowering the ascorbate concentration.
The BLM-iron-positive synovial fluids examined had lowered concentrations of transferrin and lactoferrin. Previous studies have confirmed, however, that such fluids nevertheless still have an available iron-binding capacity.
During inflammation, the pH in the microenvironment beneath adherent macrophages can fall to 5.0 or less (Etherington et al., 1981) , and therefore the pH value of 5.3 used in these studies to determine release of iron is of physiological importance. At pH 5.3 it appears that iron is preferentially released from some synovial fluids, but not from others, and it is the iron-releasing fluids which contain extremely low concentrations of antioxidant protection against iron damage. Transferrin contains two iron-binding sites, one of which can hold iron more tightly at acid pH values (Lestas, 1976) , and lactoferrin 1987
can hold its iron down to pH values of 4.0 (Groves, 1960; Johansson, 1960) . However, some iron was released to bleomycin at pH 5.3 from pure transferrin, iron-loaded at 5, 10, 20 and 40% saturation (results not shown), when all the iron would be expected to be on the tighter 'acid-binding' site.
The presence of BLM-iron in synovial fluids appears to relate directly to the low concentrations of transferrin and lactoferrin, and possibly to the higher (when compared with other arthritic patients) percentage iron saturation of the transferrin. However, it should be noted that, as a group, arthritic patients have generally a lower percentage iron saturation of transferrin than do normal controls. The possibility that the transferrin is chemically or physically different in the BLM-ironpositive fluids has yet to be established.
This study suggests that the bleomycin assay when carried out at pH 5.3 provides an important diagnostic test to distinguish arthritic patients with low degrees of anti-oxidant protection against iron-stimulated damage and a propensity to release catalytic iron in the microenvironment. The use of an iron chelator, such as lactoferrin, effective at low pH values may be beneficial in the treatment of this group of patients.
